Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 21st September 2022
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Argenta becomes NOAH member
Argenta prides itself on a 'Molecule to Market' approach, partnering across the whole development cycle of a product.
New member is specialist research and manufacturing organisation.

The National Office of Animal Health (NOAH) has announced that Argenta, global contract research organisation (CRO) and contract development and manufacturing organisation (CDMO) has become an Associate member.

Argenta, who specialises in animal health, partners with customers to develop technologies and products. The company works in pharmaceutical sciences, independent research, clinical studies and solutions, regulatory services and manufacturing.

Dawn Howard, chief executive at NOAH, welcomed the new member: “We are delighted to welcome Argenta to NOAH. 

“Their role as a specialist research and manufacturing organisation highlights how our sector contributes to the UK science base, and we look forward to working with them, helping make NOAH a stronger voice for our industry on the many challenges and opportunities we face at this time.”

Marketing specialist at Argenta, Dr Ian Williams, added: “We have joined NOAH to keep up-to-date with relevant animal health news, policy and regulatory changes. 

“We are also looking forward to the networking opportunities for Argenta with other NOAH members, that membership will bring.”

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.